|
Volumn 65, Issue 9, 2002, Pages 1871-1873
|
Migraine headache
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIMIGRAINE AGENT;
CAFFEINE;
CODEINE;
DICLOFENAC;
ELETRIPTAN;
ERGOTAMINE DERIVATIVE;
IBUPROFEN;
LYSINE ACETYLSALICYLATE;
METOCLOPRAMIDE;
NAPROXEN;
NARATRIPTAN;
NARCOTIC ANALGESIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PLACEBO;
RIZATRIPTAN;
SALICYLIC ACID DERIVATIVE;
SUMATRIPTAN;
TOLFENAMIC ACID;
ZOLMITRIPTAN;
CHRONIC PAIN;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG EFFICACY;
EVIDENCE BASED MEDICINE;
HEADACHE;
HUMAN;
MIGRAINE;
PREVALENCE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SHORT SURVEY;
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
FAMILY PRACTICE;
HUMANS;
MIGRAINE DISORDERS;
RANDOMIZED CONTROLLED TRIALS;
SEROTONIN AGONISTS;
|
EID: 0036570628
PISSN: 0002838X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (5)
|
References (14)
|